![background image](http://html1.mh-extra.com/html/neuropace/pdms-4340/pdms-4340_user-programming-manual_1676339011.webp)
Introduction
7
RNS
®
System Programming Manual
the programmed stimulation to the patient (per the device detection programming).
The physician should be aware of possible sensing artifacts when assessing the
ECoG recordings. Potential sources of RFID may occur in a health care environment,
retail stores, public libraries, airports and business environments.
Refer to
Electromagnetic Emissions and Immunity
on page
information.
WARNING:
S
ECURITY AND
E
LECTRONIC
T
RACKING
S
YSTEMS
Security screening devices (such as theft detectors, security tag deactivators, and
airport security screening devices) can result in signals that appear as ECoG activity to
the neurostimulator. Signals that appear as ECoG activity could also result in
delivering the programmed stimulation to the patient (per the device detection
programming). Such devices may be found at retail stores, public libraries and
airports. The physician should be aware of possible sensing artifacts when assessing
the ECoG recordings. Patients should be instructed to walk through the center of such
security screening units without stopping, when possible, and exit the area of the
screening device as soon as possible.
WARNING:
N
EURO
P
ACE
C
OMPONENTS
Use of accessories, transducers, and cables other than those provided by NeuroPace
could result in increased electromagnetic emissions or decreased electromagnetic
immunity of the RNS
®
System and result in improper operation.
WARNING:
P
ORTABLE AND
M
OBILE
R
ADIO
F
REQUENCY
(RF)
C
OMMUNICATIONS
E
QUIPMENT
Portable and mobile RF communications equipment (including peripherals such as
antenna cables and external antennas) should be used no closer than 12 inches (30
cm) to any part of the RNS
®
System, including cables. Otherwise, degradation of the
performance of the RNS
®
System could result.
WARNING:
N
EURO
P
ACE
®
E
QUIPMENT
P
LACEMENT
Use of NeuroPace
®
equipment (for example, remote monitor or programmer) adjacent
to or stacked with other equipment should be avoided because it could result in
improper operation. If such use is necessary, the NeuroPace
®
equipment and other
equipment should be observed to verify that they are operating normally.
Caution:
Telemetry Artifact
Telemetry may produce an electrographic artifact. If responsive therapy is enabled
with a sensitive detection set, detection of the electrographic artifact may occur
resulting in therapy delivery. The physician should be aware of possible sensing
artifacts when assessing the ECoG recordings.
Caution:
Afterdischarge Activity
If evidence of afterdischarge activity resulting from stimulation is seen either on stored
ECoGs or during test stimulation delivery, stimulation parameters should be adjusted
to prevent such occurrence.
Summary of Contents for PDMS 4340
Page 119: ......